Treatment of hepatitis B virus-associated nephropathy in black children

Pediatric Nephrology

Volumn 17, Issue 6, 2002, Pages 393-399

  Bhimma, Rajendra ^a,b   Coovadia, Hoosen Mohamed ^a,b   Kramvis, Anna ^a,b   Adhikari, Mirriam ^a,b   Kew, Michael Charles ^a,b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Hepatitis B virus; Interferon; Membranous nephropathy; Nephrotic syndrome; Proteinura

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; CYTOTOXIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; LIVER ENZYME; RECOMBINANT ALPHA2B INTERFERON; STEROID; THIAZIDE DIURETIC AGENT; VIRUS DNA;

ADOLESCENT; ANEMIA; ANTIVIRAL ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONVULSION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; FEVER; FLU LIKE SYNDROME; HEADACHE; HEPATITIS B VIRUS; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INFANT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; LEUKOPENIA; LIVER FUNCTION; MALE; MENTAL DISEASE; MYALGIA; NEGRO; NEPHROTIC SYNDROME; OPEN STUDY; PRIORITY JOURNAL; PROTEINURIA; THROMBOCYTOPENIA;

ADOLESCENT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DNA, VIRAL; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON ALFA-2B; KIDNEY; KIDNEY DISEASES; LIVER; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036940397     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-001-0814-x     Document Type: Article

References (35)

1. Coombes B, Stastny P, Shorey J, Engenbrodt EH, Barrera A, Hull AR, Cater NW (1971) Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet 2:234-236
2. Wyszyska T, Jung H, Madalinski K, Morzycka M (1984) Hepatitis B mediated glomerulonephritis in children. Pediatr Nephrol 5:147-150
3. Bhimma R, Coovadia HM, Adhikari M (1998) Hepatitis B virus-associated nephropathy in black South African children. Pediatr Nephrol 12:479-484
4. Lin CY (1990) Hepatitis B virus associated membranous nephropathy: clinical features, immunological profiles and outcomes. Nephron 55:37-44
5. Lin CY (1991) Clinical features and natural course of HBV-related glomerulopathy in children. Kidney Int 40:S46-S53
6. Rodney DG, Wiggelinkhuizen J (1994) The clinical course of hepatitis B virus-associated nephropathy. Pediatr Nephrol 8:11-14
7. Kleinknecht C, Levy M, Peix A, Broyer M, Courtecuisse V (1979) Membranous glomerulonephritis and hepatitis B surface antigenaemia in children. J Pediatr 95:946-952
8. Elidressey ATH, Abdurrahman MB, Raima S, Lynch JB (1988) Hepatitis B surface antigen associated nephrotic syndrome. Ann Trop Paediatr 8:157-161
9. Levy M, Chen Nan (1991) Worldwide perspective of hepatitis B-associated glomerulonephritis in the 80s. Kidney Int 40 Suppl 35:S24-S33
10. Lin CY (1991) Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int 47:225-230
11. Haria M, Banfield P (1995) Interferon α-2a: a review of its pharmacological properties and therapeutic use in management of viral hepatitis. Drugs 50:873-896
12. Phillips TM (1996) Interferon-α induces renal dysfunction and injury. Curr Opin Nephrol Hypertens 5:380-383
13. Belardelli F, Gressor I (1996) The neglected role of type 1 interferon in the T-cell response: implications for its clinical use. Immunol Today 17:369-372
14. Wakeel JA, Mitwalli A, Tarif N, Al-Mohaya S, Malik G, Khalil M (1999) Role of interferon-α in the treatment of primary glomerulonephritis. Am J Kidney Dis 33:1142-1146
15. Wong DK, Cheung AM, Órourke K, Naylor CD, Detsky AS, Heathcote J (1993) Effect of alpha interferon treatment in patients with hepatitis B e antigen positive chronic hepatitis B. A meta-analysis. Ann Intern Med 119:312-323
16. Conjeevaram HS, Hoofnagel JH, Austin HA, Park Y, Fried MW, DiBisceglie AM (1995) Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alpha. Gastroenterology 109:540-546
17. Abbas NA, Pitt MA, Green AT, Solomon LR (1999) Successful treatment of hepatitis B virus (HBV)-associated membranoproliferative glomerulonephritis (MPGN) with alpha interferon. Nephrol Dial Transplant 14:1272-1275
18. Barratt TM, Beattie JM, Coleman J, Dossetor JS, Fradd E, Hopkins A, Houston IB, Joseph A, Mallick N, Plant N, Watson AR, White RHR, Valman B, Jones KV (1994) Consensus statement of management and audit potential to steroid responsive nephrotic syndrome. Arch Dis Child 70:151-157
19. Smuts HE, Kannemeyer J (1995) Genotyping of hepatitis C virus in South Africa. J Clin Microbiol 33:1679-1681
20. Counahan R, Chantler C, Chazali S, Kirkwood B, Rose F, Barratt TM (1976) Estimation of glomerular filtration rate from the plasma creatinine in children. Arch Dis Child 51:875-878
21. Pesce MA, Strande CS (1973) A new micromethod for determination of protein in cerebrospinal fluid and urine. Clin Chem 19:1265-1267
22. Husdan H, Rappoport A (1968) Estimation of creatinine by the Jaffe reaction: comparison of three methods. Clin Chem 14: 222-238
23. Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC Jr, Lindsay K, Payne J, Dienstag JL, Óbrien C, Tamburro C, Jacobson IM, Sampliner R, Feit D, Lefkowitch J, Kuhns M, Meschievitz C, Sanghvi B, Alrecht J, Gibas A, and the Hepatitis Interventional Therapy Group (1990) A randomised, controlled trial of interferon alpha-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 5:295-301
24. Aikeda M, Minota S, Kano S (1997) Regulation of MHC class 1 expression by inflammatory cytokines in rat mesangial cells. Nephron 76:90-95
25. Porres JC, Carreno V, Ruiz M, Marron JA, Bartolome J (1989) Interferon antibodies in patients with chronic HBV infection treated with recombinant interferon. J Hepatol 8:351-357
26. Mizushima N, Kanai K, Matsuda H, Matsumoto M, Tamakoshi K, Ishii H, Nakajima T, Yoshima T, Kimura M, Nagase M (1987) Improvement of proteinuria in a case of hepatitis B-associated glomerulonephritis after treatment with interferon. Gastroenterology 92:524-526
27. Taniguchi T (1988) Regulation of cytokine gene expression. Annu Rev Immunol 6:439-464
28. Beresini MH, Lepert MJ, Epstein LB (1988) Overlapping polypeptide induction in human fibroblasts in response to treatment with interferon-alpha, interferon-gamma, interleukin-alpha and tumor necrosis factor. J Immunol 140:485-493
29. Cattran DC, Greenwood C, Ritchie S, Bernstein K, Churchill DN, Clark WF, Morrin PA, Lavoie S (1995) A controlled trial of cyclosporin in patients with progressive membranous nephropathy. Kidney Int 47:1130-1135
30. Chung DR, Yang WS, Kim SB, Yu E, Chung YH, Lee Y, Park JS (1997) Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon. Am J Nephrol 17:112-117
31. Takekoshi Y, Shida N, Saheki Y, Tanaka M, Satake Y, Matsumoto S (1978) Strong association between membranous nephropathy and hepatitis-B surface antigenaemia in Japanese children. Lancet ii:1065-1068
32. Southwest Pediatric Nephrology Study Group (1985) Hepatitis B surface antigenaemia in North American children with membranous glomerulonephropathy. J Pediatr 106:571-577
33. Yoshikawa Y, Tanaka M (1987) Hepatitis B virus-associated glomerulonephritis in children. In: Murakami K, Kitagawa T, Yabuta K, Sakai T (eds) Recent advances in pediatric nephrology. Excerpta Medica, New York, pp 293-298
34. Lisker-Melman M, Webb D, Di Bisceglie AM, Kassianides C, Martin P, Rustgi V, Waggoner JG, Park Y, Hoofnagel JH (1989) Ann Intern Med 111:479-483
35. Louis-Jacques O, Olson AD (1997) Cost-benefit analysis of interferon therapy in children with chronic active hepatitis B. J Pediatr Gastroenterol Nutr 241:25-32